Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC DSR-6434 | 1059070-10-8 | 99.3% | 400.48 | 50 MG
SDP

Catalog No. 5000344243
Encompass_Preferred

DSR-6434 is a potent and selective Toll-like receptor 7 (TLR7) agonist, with EC50s of 7.2 nM and 4.6 nM for human and mice TLR7, respectively. It has a strong antitumor effect. DSR-6434 stimulates reporter gene activity only in HEK293 cells expressing hTLR7 and not in HEK293 cells expressing the structurally similar hTLR8 or hTLR9. In vivo, treatment suppresses lung metastasis significantly.

  • Potent and selective Toll-like receptor 7 (TLR7) agonist.
  • EC50s of 7.2 nM for human TLR7 and 4.6 nM for mice TLR7.
  • Strong antitumor effect.
  • Stimulates reporter gene activity only in HEK293 cells expressing hTLR7.
  • Suppresses lung metastasis significantly in vivo.

Catalog No. 50-003-44243 Supplier Medchemexpress LLC Supplier No. HY11012010MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DSR-6434 is a potent and selective Toll-like receptor 7 (TLR7) agonist, with EC50s of 7.2 nM and 4.6 nM for human and mice TLR7, respectively. It has a strong antitumor effect. DSR-6434 stimulates reporter gene activity only in HEK293 cells expressing hTLR7 and not in HEK293 cells expressing the structurally similar hTLR8 or hTLR9. In vivo, treatment suppresses lung metastasis significantly.

  • Potent and selective Toll-like receptor 7 (TLR7) agonist.
  • EC50s of 7.2 nM for human TLR7 and 4.6 nM for mice TLR7.
  • Strong antitumor effect.
  • Stimulates reporter gene activity only in HEK293 cells expressing hTLR7.
  • Suppresses lung metastasis significantly in vivo.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.